
    
      Following the screening, eligible subjects entered a 3-day, single-blind placebo run-in. On
      Day 4, each subject was randomized to a treatment sequence that included three treatment
      assignments for each of three treatment Periods according to the randomization scheme.

      Pre-assignment Details The number of participants receiving each Intervention, in each
      Period, is reported.

      Subjects received the randomized treatment from Day 4 through Day 8. There was a 24-hour
      single-blind placebo washout on Day 9. Each subject received placebo for one of the three
      treatment periods. Each subject also received 1 of the 3 active doses randomly in each of the
      two other treatment periods respectively. The dosing order is random.
    
  